To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Apax in $1.2bn healthcare exit
The firm has clinched its second healthcare exit since August with the sale of Qualitest Pharmaceuticals to a strategic buyer.
